Novel Inflammasome Targets Relevant To Alzheimer’s Disease
Time: 2:00 pm
day: Day 2 - Track B - Afternoon
Details:
- Alzheimer’s disease is a disease of both proteinopathy and immunopathy
- New therapeutic directions affecting the innate immune system, especially targets that impact on microgliamediated inflammation
- Case studies in two areas of drug discovery at our Institute
